Owa J A, Durosinmi M A, Alabi A O
Department of Paediatrics & Child Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
Trop Doct. 1991 Jan;21(1):19-22. doi: 10.1177/004947559102100108.
The study was designed to determine factors responsible for the severe neonatal hyperbilirubinaemia sometimes found in ABO incompatibility in Nigeria. In 50 jaundiced babies who were ABO-incompatible it was found that the mean serum bilirubin level was significantly higher in outpatients than inpatients; this difference was probably due to the delay in recognizing jaundice among the outpatients and, possibly also to the slightly higher number of G-6-PD deficient babies in the same group, and their greater exposure to icterogenic agents. The results of serological studies suggest that ABO-incompatibility was responsible for neonatal jaundice in only 36% of these babies. Among the inpatients the need for exchange blood transfusion was more common in babies of mothers with immune anti-A or anti-B titres of 1:64 or more (P less than 0.001). Neonates at risk of ABO-haemolytic disease can be identified at birth by direct positive Coombs test and detection of immune anti-A or anti-B antibodies in the mother's serum.
本研究旨在确定在尼日利亚ABO血型不相容时有时会出现的严重新生儿高胆红素血症的相关因素。在50例ABO血型不相容的黄疸婴儿中,发现门诊患儿的平均血清胆红素水平显著高于住院患儿;这种差异可能是由于门诊患儿黄疸识别延迟,也可能是由于同一组中G-6-PD缺乏婴儿的数量略多,以及他们接触致黄疸剂的机会更多。血清学研究结果表明,ABO血型不相容仅导致这些婴儿中36%的新生儿黄疸。在住院患儿中,母亲免疫抗A或抗B效价为1:64或更高的婴儿更常需要换血治疗(P小于0.001)。出生时通过直接抗人球蛋白试验阳性以及检测母亲血清中的免疫抗A或抗B抗体,可以识别有ABO溶血病风险的新生儿。